NICE Committee Meets Re: Spinraza Access

The SMA Trust attended the NICE (National Institute of Health and Care Excellence) Committee meeting relating to Spinraza access in England, on Wednesday 27th June, in Manchester. The Committee considered clinical and economic evidence, supporting the funding of the treatment, as well as listening to powerful accounts from patient representatives. Thanks and well done to everyone involved. Following the session, there will be a follow-up closed meeting held on 31st July with a final decision expected to be announced on 21st November 2018.




Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.